3 news items
Jazz Pharmaceuticals Showcases Pioneering Research in Sleep Medicine at SLEEP 2024
JAZZ
30 May 24
with serious conditions, such as narcolepsy and idiopathic hypersomnia, which are chronic, debilitating neurologic sleep disorders that often require lifelong
NodThera Announces Appointment of Daniel Swisher as Chief Executive Officer
JAZZ
28 May 24
pioneering work in CNS modulation of chronic inflammatory diseases BOSTON, MA, May 28
Jazz Pharmaceuticals to Showcase Expansive Neuroscience Portfolio at American Academy of Neurology Annual Meeting
JAZZ
10 Apr 24
on the FDA findings that Xywav provides a greatly reduced chronic sodium burden compared
- Prev
- 1
- Next